These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8200078)

  • 61. Suppression of sulfoconjugation reduces the protective effect of ortho-aminoazotoluene on hepatocarcinogenesis induced by diethylnitrosamine in mice.
    Kaledin VI; Il'nitskaya SI; Popova NA; Bogdanova LA
    Bull Exp Biol Med; 2014 Jul; 157(3):368-70. PubMed ID: 25065317
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 32P-postlabeling analysis of DNA adducts in rats during estrogen-induced hepatocarcinogenesis and effect of tamoxifen on DNA adduct level.
    Shimomura M; Higashi S; Mizumoto R
    Jpn J Cancer Res; 1992 May; 83(5):438-44. PubMed ID: 1319983
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Improvement in the diagnostic potential of 32P-postlabeling analysis demonstrated by the selective formation and comparative analysis of nitrated-PAH-derived adducts arising from diesel particle extracts.
    Gallagher JE; Kohan MJ; George MH; Lewtas J
    Carcinogenesis; 1991 Sep; 12(9):1685-91. PubMed ID: 1893529
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Metabolic activation of 9-hydroxymethyl-10-methylanthracene and 1-hydroxymethylpyrene to electrophilic, mutagenic and tumorigenic sulfuric acid esters by rat hepatic sulfotransferase activity.
    Surh YJ; Blomquist JC; Liem A; Miller JA
    Carcinogenesis; 1990 Sep; 11(9):1451-60. PubMed ID: 2205404
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Identification of tamoxifen-DNA adducts in monkeys treated with tamoxifen.
    Shibutani S; Suzuki N; Laxmi YR; Schild LJ; Divi RL; Grollman AP; Poirier MC
    Cancer Res; 2003 Aug; 63(15):4402-6. PubMed ID: 12907611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Application of the 32P-postlabelling assay to the inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-DNA adduct formation by dietary fatty acids.
    Schut HA; Zu HX
    IARC Sci Publ; 1993; (124):181-8. PubMed ID: 8225482
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of molybdate and pentachlorophenol on the sulfation of dehydroepiandrosterone.
    Boles JW; Klaassen CD
    Toxicol Appl Pharmacol; 1998 Jul; 151(1):105-9. PubMed ID: 9705892
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inefficient repair of tamoxifen-DNA adducts in rats and mice.
    Kim SY; Suzuki N; Laxmi YR; Shibutani S
    Drug Metab Dispos; 2006 Feb; 34(2):311-7. PubMed ID: 16299164
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of covalent DNA adducts in rodents by tamoxifen.
    Han XL; Liehr JG
    Cancer Res; 1992 Mar; 52(5):1360-3. PubMed ID: 1737398
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dose-related differences in DNA adduct levels in rodent tissues following skin application of complex mixtures from air pollution sources.
    Gallagher JE; Jackson MA; George MH; Lewtas J
    Carcinogenesis; 1990 Jan; 11(1):63-8. PubMed ID: 2403860
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detection of mitomycin C-DNA adducts in vivo by 32P-postlabeling: time course for formation and removal of adducts and biochemical modulation.
    Warren AJ; Maccubbin AE; Hamilton JW
    Cancer Res; 1998 Feb; 58(3):453-61. PubMed ID: 9458089
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Human enzymes involved in the metabolic activation of the environmental contaminant 3-nitrobenzanthrone: evidence for reductive activation by human NADPH:cytochrome p450 reductase.
    Arlt VM; Stiborova M; Hewer A; Schmeiser HH; Phillips DH
    Cancer Res; 2003 Jun; 63(11):2752-61. PubMed ID: 12782579
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f] quinoline in male Fischer-344 rats.
    Zu HX; Schut HA
    Cancer Res; 1991 Oct; 51(20):5636-41. PubMed ID: 1913681
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxo substituents markedly alter the phase II metabolism of alpha-hydroxybutenylbenzenes: models probing the bioactivation mechanisms of tamoxifen.
    Ramakrishna KV; Fan PW; Boyer CS; Dalvie D; Bolton JL
    Chem Res Toxicol; 1997 Aug; 10(8):887-94. PubMed ID: 9282838
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mutagenic activation reduces carcinogenic activity of ortho-aminoazotoluene for mouse liver.
    Ovchinnikova LP; Bogdanova LA; Kaledin VI
    Bull Exp Biol Med; 2013 Mar; 154(5):664-8. PubMed ID: 23658894
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tamoxifen: is it safe? Comparison of activation and detoxication mechanisms in rodents and in humans.
    White IN
    Curr Drug Metab; 2003 Jun; 4(3):223-39. PubMed ID: 12769667
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enzymatic sulfation of steroids--XX. Effects of ten drugs on the hepatic glucocorticoid sulfotransferase activity of rats in vitro and in vivo.
    Singer SS; Ansel AZ; Van Brunt N; Torres J; Galaska EG
    Biochem Pharmacol; 1984 Nov; 33(21):3485-90. PubMed ID: 6594138
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protection from drug-induced hepatocellular changes by pretreatment with conjugating enzyme inhibitors in rats.
    Sato G; Aoki T; Hosokawa S; Sagami F; Tsukidate K
    Life Sci; 2001 May; 68(24):2665-73. PubMed ID: 11400910
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hepatic macromolecular covalent binding of mononitrotoluenes in Fischer-344 rats.
    Rickert DE; Long RM; Dyroff MC; Kedderis GL
    Chem Biol Interact; 1984 Dec; 52(2):131-9. PubMed ID: 6595071
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metabolic Activation and Cytotoxicity of Aloe-Emodin Mediated by Sulfotransferases.
    Li R; Li W; You Y; Guo X; Peng Y; Zheng J
    Chem Res Toxicol; 2019 Jun; 32(6):1281-1288. PubMed ID: 31046239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.